$21,993 in research paymentsEnzalutamide
Dr. Daniel Peter Petrylak, MD
NPI1659387306PAC ID4981651155
- Medicare services, 2024
- 797
- Medicare patients, 2024
- 265
- Part D claims, 2024
- 394
- Clinical trials
- 2
- MIPS score, 2024
- 87
- Practice address
- 50 Division St, New Haven, CT 06511
- Practice phone
- Call (203) 785-2140
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Yale Medicine
New Haven, Connecticut
Find Dr. Petrylak's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Daniel Peter Petrylak is a medical oncologist in New Haven, Connecticut
Dr. Petrylak practices at Yale Medicine in New Haven, Connecticut.
Dr. Petrylak's NPI, 1659387306, was assigned on August 1, 2006. Dr. Petrylak graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 1985. Dr. Petrylak holds Connecticut license 51405.
NPI and contact details
- NPI
- 1659387306NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4981651155
- NPI enumeration date
- August 1, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (203) 785-2140
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 67
- Medical school graduation
- 1985
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Daniel Peter Petrylak practices at Yale Medicine in New Haven, Connecticut
Dr. Petrylak's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.
- Yale Medicine50 Division St, New Haven, CT 06511 · South Central Ct CountyPhone(203) 785-2140
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Daniel Peter Petrylak is affiliated with 6 sites of care and 2 medical groups
Dr. Petrylak's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Petrylak is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Petrylak to 4 more hospitals and 1 medical group, each named with a free account.
Yale MedicinePrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Daniel Peter Petrylak's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Petrylak practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Yale Medicine | Available with a free account |
| +5 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Petrylak practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Daniel Peter Petrylak is one of 80 medical oncologists in Connecticut
Medical oncology is Dr. Petrylak's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Petrylak's licenses on file in 2 states: Connecticut and New York.
Specialties and state licenses
- Medical oncology, ConnecticutPrimary
- Hematology and oncology, New York
Medical oncologists near Dr. Petrylak
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Daniel Peter Petrylak billed Medicare for 797 services in 2024
CMS data shows 797 Medicare services from Dr. Petrylak across 5 procedure codes in 2024, for 265 Medicare patients. Medicare paid $61,517 for them.
Medicare services, 2024797
Medicare patients265
Paid by Medicare$61,517
Procedure codes5
Dr. Petrylak's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 7802024: 7972%
Where Dr. Petrylak's Medicare services took place, 2024
- In an office9011%
- In a facility70789%
Dr. Petrylak compared with the Connecticut median for medical oncologists, 2024
- Dr. Petrylak
- Connecticut median
- Medicare services
- 797vs 2523.2 times
- Medicare patients
- 265vs 962.8 times
- Part D claims
- 243vs 19624% above
Medians across 76 medical oncologists in Connecticut with Dmand AI profiles that report each measure.
Dr. Petrylak's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Petrylak?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Petrylak and other medical oncologists in Connecticut.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Daniel Peter Petrylak treated 265 Medicare patients in 2024, average age 77
CMS counts 265 Medicare patients who saw Dr. Petrylak in 2024. The largest group is 65 to 74, with 113 patients. 75% of them have cancer, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Petrylak's median patient age at 77, with 4% women.
Medicare patients, 2024265
Average age77
Average risk score2.09
Also on Medicaid5%
Dr. Petrylak's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Petrylak's Medicare patients, 2024
- Cancer75%
- High cholesterol75%
- High blood pressure74%
- Arthritis48%
- Ischemic heart disease37%
- Diabetes27%
- Atrial fibrillation22%
- Chronic kidney disease21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Petrylak's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 77
Patient panel by sex, all payers
- Women4%
- Men95%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Daniel Peter Petrylak wrote 394 Medicare Part D claims in 2024
In 2024, Dr. Petrylak wrote 394 Medicare Part D claims for 72 patients. 57% of them were for generic drugs. CMS names the drug for 243 of them, across 6 drugs with 11 or more claims each, at $2,035,827 in total drug cost. In 2023, CMS named 352 claims across 10 drugs.
Part D claims, 2024394
Drugs named by CMS6
Total drug cost$2M
Part D patients72
Dr. Petrylak's Part D claims by kind of drug, 2024
- Generic226 claims57%
- Brand-name and other168 claims43%
Dr. Petrylak's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Petrylak's Part D claims, 2024
- Opioids4%15 of 394 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3522024: 24331%
Drugs named by CMS: 6 in 2024, 10 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Daniel Peter Petrylak scored 87 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Petrylak for performance year 2024, reported as part of a group. Dr. Petrylak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Petrylak as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Petrylak's MIPS scores, performance year 2024
- 87of 100Final score
- 77.4of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 74of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find medical oncologists like Dr. Petrylak by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Daniel Peter Petrylak has worked on 2 clinical trials
Dmand AI links Dr. Petrylak to 2 clinical trials. Conditions studied include Ureteral Neoplasms and Urethral Neoplasms. Open Payments lists research payments to Dr. Petrylak that name 2 trials.
Conditions in Dr. Petrylak's trials
- Ureteral Neoplasms
- Urethral Neoplasms
Investigators on the most trials with Dr. Petrylak
- Andrew John Armstrong, MD1 shared trial
- Tomasz M. Beer, MD1 shared trial
- Mehmet Asim Bilen, MD1 shared trial
Recent clinical trials with Dr. Petrylak
$256 in research paymentsUreteral NeoplasmsUrethral NeoplasmsEnfortumab vedotin
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Daniel Peter Petrylak received $705,982 in industry payments from 2016 to 2025
CMS Open Payments shows 760 general payments to Dr. Petrylak from 45 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Merck Sharp & Dohme Corporation paid the most, $62,193. It also lists 215 research payments totaling $81,808 from 2017 to 2025, naming 2 clinical trials.
General payments to Dr. Petrylak by program year, 2016 to 2025
General payments to Dr. Petrylak by kind, 2016 to 2025
$706Kin total
- Consulting fees$503,07272%
- Speaker and faculty fees$78,22211%
- Travel and lodging$73,67011%
- Food and beverage$21,3323%
- Other$23,7163%
Companies that paid Dr. Petrylak the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Daniel Peter Petrylak graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University
Dr. Petrylak graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 1985.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Daniel Peter Petrylak's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Daniel Peter Petrylak
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Daniel Peter Petrylak's NPI number?
Dr. Daniel Peter Petrylak's NPI number is 1659387306. It was assigned on August 1, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Daniel Peter Petrylak?
Dr. Daniel Peter Petrylak is a medical oncologist in New Haven, Connecticut. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Daniel Peter Petrylak practice?
Dr. Petrylak practices at 50 Division St, New Haven, CT 06511. Dr. Petrylak's primary practice is Yale Medicine in New Haven, Connecticut. Dmand AI also links Dr. Petrylak to 4 hospitals and 1 medical group.
What is Dr. Daniel Peter Petrylak's office phone number?
The practice phone on file for Dr. Petrylak is (203) 785-2140.
What is Dr. Daniel Peter Petrylak's medical license number?
Dr. Petrylak holds Connecticut license 51405, one of the licenses on file in 2 states.
Which states has Dr. Daniel Peter Petrylak been licensed in?
Dmand AI has state licenses on file for Dr. Petrylak in Connecticut and New York.
Which hospitals is Dr. Daniel Peter Petrylak affiliated with?
Dr. Petrylak is affiliated with Yale New Haven Hospital. Dmand AI links Dr. Petrylak to 4 more hospitals.
What medical group is Dr. Daniel Peter Petrylak part of?
Dr. Petrylak is linked to Yale Health. Dmand AI links Dr. Petrylak to 1 more medical group.
Does Dr. Daniel Peter Petrylak accept Medicare?
Yes. CMS data shows Dr. Petrylak billed Medicare for 797 services in 2024, and Dr. Petrylak accepts Medicare assignment.
Does Dr. Daniel Peter Petrylak offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Petrylak as offering telehealth services.
Show 8 more questionsShow fewer questions
What is Dr. Daniel Peter Petrylak's MIPS score?
Dr. Petrylak's MIPS final score for performance year 2024 is 87 out of 100, reported as part of a group.
How many Medicare patients does Dr. Daniel Peter Petrylak see?
CMS counts 265 Medicare patients who saw Dr. Petrylak in 2024, with an average age of 77.
What services does Dr. Daniel Peter Petrylak bill to Medicare?
In 2024, Dr. Petrylak's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and office visit, established patient (99215).
Where did Dr. Daniel Peter Petrylak go to medical school?
Dr. Petrylak graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 1985.
What drugs does Dr. Daniel Peter Petrylak prescribe most?
In 2024 Medicare Part D data, Dr. Petrylak's most prescribed drugs by claims were Xtandi, Prednisone and Nubeqa.
Has Dr. Daniel Peter Petrylak received payments from drug or device companies?
CMS Open Payments shows $705,982 in general payments to Dr. Petrylak from 45 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Daniel Peter Petrylak been practicing?
Dr. Petrylak graduated from medical school in 1985, 41 years ago.
Does Dr. Daniel Peter Petrylak do research?
Dr. Petrylak has worked on 2 clinical trials.
Selling to medical oncology practices?
See medical oncologists in Connecticut by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card